Search

Author/Creator Tellier, Z.

2. Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study. Issue 2 (13th December 2017)

Authors:
Négrier, C.; Ducloy‐Bouthors, A.‐S.; Piriou, V.; De Maistre, E.; Stieltjes, N.; Borel‐Derlon, A.; Colson, P.; Picard, J.; Lambert, T.; Claeyssens, S.; Boileau, S.; Bertrand, A.; André, M.‐H.; Fourrier, F.; Ozier, Y.; Sié, P.; Gruel, Y.; Tellier, Z.
Journal:
Vox sanguinis
Issue:
Volume 113:Issue 2(2017)
Page Start:
120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Post‐authorization safety study of Clottafact®, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study. Issue 4 (1st September 2016)

Authors:
Négrier, C.; Rothschild, C.; Borg, J.‐Y.; Lambert, T.; Claeyssens, S.; Sanhes, L.; Stieltjes, N.; Bertrand, A.; André, M.‐H.; Sié, P.; Gruel, Y.; Tellier, Z.
Journal:
Vox sanguinis
Issue:
Volume 111:Issue 4(2016)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search